Néoplasies associées à une sclérodermie systémique avec anticorps anti-ARN polymérase III
J.‐B. Monfort(Sorbonne Université), Patricia Senet(Sorbonne Université), Alexis Mathian(Inserm), C. Françès(Navarre Institute of Health Research), Zahir Amoura(Inserm), A. Barbaud(Sorbonne Université)
Cited by 6
Related Papers
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
|Immunity|2009|2.3k
The immune paradox of sarcoidosis and regulatory T cells
|The Journal of Experimental Medicine|2006|444
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
|The Lancet Rheumatology|2021|292
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262